California court certifies unlikely class — will it redefine the class action landscape?
By Stefanie Jill Fogel, George Gigounas and Rachael E Yourtz
In food marketing litigation, class certification is a major hurdle for would-be class plaintiffs, but a recent case out in the Central District of California may have lowered the bar with a flexible approach to class certification.
In Forcellati v Hyland, the plaintiffs, on behalf of a purported class, allege that Hyland misrepresented its Hyland’s Homeopathic products as providing fast, safe and effective relief from cold and flu symptoms when in fact they are merely placebos.
The court certified the nationwide class over Hyland’s opposition. The allegations spanned five different products, all with different ingredients, made to treat different symptoms, and all with varying advertisements. According to the Forcellati v Hyland court, the only relevant question was whether the defendants ‘misrepresent that their products safely and effectively treat cold and flu symptoms when, in fact, they have no medicinal value whatsoever’…
Click on the link below to read the rest of the DLA Piper briefing.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Global Financial Markets Insight — the case for a better-functioning securitisation market; the cost of holding ABS; and more
DLA Piper has released the latest version (issue 4, Q3 2014) of its Global Financial Markets Insight publication.
Corporate Insurance Trends 2014 is a collection of articles highlighting some trends and key issues for financial lines insurers and their insureds in 2014.
Analysis from The Lawyer
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions